A team of Gleiss Lutz lawyers advised Aspirant Group, a Japanese private equity investor, on the German aspects of its acquisition of a stake in DIPSOL Chemical Co., Ltd.
The Japanese company DIPSOL was founded in 1953 with the name Toei Chemicals and then renamed DIPSOL Chemical in 1968. DIPSOL is a leading global specialist in the development and production of surface treatment technologies to improve the durability and functionality of metal surfaces. The company has 17 branches in 12 countries, including in Düsseldorf. In its home market, Japan, DIPSOL is a market leader for functional zinc and zinc alloy systems and thus an important supplier for automobile manufacturers and tier 1 suppliers.
Aspirant Group is engaged in the private equity business and supports companies in terms of their strategic development in order to promote sustainable and long-term growth.
The following team of Gleiss Lutz lawyers advised Aspirant Group on the transaction: Dr. Michael Burian (partner, lead), Dr. Christopher Vogl (both Stuttgart), Jannik Hermes (Frankfurt, all M&A).
Gleiss Lutz has a leading Japan practice and regularly advises Japanese companies on M&A transactions – in 2020, among others, the NEC Corporation on its acquisition of Avaloq and Mitsubishi Chemical on its acquisition of Gelest.
Forward
